Pharming Group N.V. ADS (PHAR)
NASDAQ: PHARHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PHAR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $683.01M
- P/E (TTM)
- 74.23
- Forward P/E
- 31.43
- EPS (TTM)
- $0.13
- Dividend yield
- None
- 52-week range
- 9.59 – 21.34
- Day range
- 9.59 – 9.75
- Volume / Avg
- 3.83K / 22.88K
- Beta
- —
- Shares outstanding
- 70.78M
- Next earnings
- Nov 5, 2026
52-week range
PHAR stock today
Shares of Pharming Group N.V. (PHAR) finished lower on Oct 7 at $9.65, a drop of 0.31% or $0.03 per share, versus the S&P 500's 0.22% decline. Trading was light, with 3.83K shares changing hands, about 17% of the average daily volume. Shares are 54.8% below their 52-week high of $21.34, set on Jan 27, 2026 and 0.6% above the 52-week low of $9.59, near the bottom of the past year's range.
PHAR is down 45.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 34.2%. At 74.2x trailing earnings, Pharming Group N.V. trades above the peer-group median of 12.0x. Its forward P/E of 31.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Pharming Group N.V.'s next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Pharming Group N.V.
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.12
Pharming Group N.V. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs PHAR |
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs PHAR |
| NVCTNuvectis Pharma Inc. | 20.29 | +1.30% | $662.35M | vs PHAR |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs PHAR |
| ABUSArbutus Biopharma Corporation | 4.29 | -4.24% | $657.55M | vs PHAR |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs PHAR |
| FTHFaeth Therapeutics Inc. | 24.92 | -7.33% | $643.94M | vs PHAR |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs PHAR |
Indexes, lists and sector
Largest Health Care stocks
Pharming Group N.V. stock FAQ
What is Pharming Group N.V.'s stock price today?
PHAR last traded at $9.65 as of Oct 7, 4:00 PM EDT, down 0.31% on the day. Prices are delayed at least 15 minutes.
When is Pharming Group N.V.'s next earnings date?
Pharming Group N.V. is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.12.
What is PHAR's P/E ratio?
PHAR trades at a trailing P/E ratio of 74.23 and a forward P/E of 31.43, compared with a median of 12.0 for its closest peers.
What is the PHAR 52-week high?
The 52-week high for PHAR is $21.34 and the 52-week low is $9.59. The stock is currently 54.8% below its high.